PETER R WOLFE
Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease LOS ANGELES, CA NPI 1407910201
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease CA ViiV Healthcare Company All categories
General Payments — all program years on this page
$10,734.41
- Category: General Payments
- Program years: PY2018–2024
- Record count: 484
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $3,171.05 across 136 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $3,171.05 | 136 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ViiV Healthcare Company | $1,285.54 | 55 |
| Gilead Sciences, Inc. | $357.22 | 12 |
| EMD Serono, Inc. | $216.67 | 7 |
| Merck Sharp & Dohme Corporation | $207.92 | 7 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $172.60 | 8 |
| Napo Pharmaceuticals Inc | $149.47 | 6 |
| Lilly USA, LLC | $149.32 | 10 |
| Amgen Inc. | $117.01 | 6 |
| Acerta Pharma LLC | $84.28 | 5 |
| Bausch Health US, LLC | $82.07 | 4 |
| Theratechnologies Inc. | $81.98 | 3 |
| ITI, Inc. | $53.86 | 2 |
| Antares Pharma, Inc. | $47.23 | 3 |
| GlaxoSmithKline, LLC. | $39.13 | 2 |
| Novo Nordisk AS | $34.02 | 2 |
| ABBVIE INC. | $27.02 | 1 |
| Exact Sciences Corporation | $23.72 | 1 |
| Axsome Therapeutics, Inc. | $21.70 | 1 |
| Corcept Therapeutics | $20.29 | 1 |
By program year
Records — PY2024 (136)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.